PMS31 - SECUKINUMAB AS A MORE EEFICIENT ALTERNATIVE FOR ANKYLOSING SPONDYLITIS TREATMENT- A COST PER RESPONDER ANALYSIS FROM KOREAN PERSPECTIVE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1745
https://www.valueinhealthjournal.com/article/S1098-3015(18)35047-2/fulltext
Title :
PMS31 - SECUKINUMAB AS A MORE EEFICIENT ALTERNATIVE FOR ANKYLOSING SPONDYLITIS TREATMENT- A COST PER RESPONDER ANALYSIS FROM KOREAN PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35047-2&doi=10.1016/j.jval.2018.09.1745
First page :
Section Title :
Open access? :
No
Section Order :
1107